1. Clinical Significance of Nodal Positivity Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
- Author
-
Preeti Yadav, Sampada B. Dessai, Adarsh Dharmarajan, B. Satheeshan, Noori Khalid, Sithara Arvind, and Bindu Anilkumar
- Subjects
Oncology ,medicine.medical_specialty ,Chemotherapy ,business.industry ,medicine.medical_treatment ,Obstetrics and Gynecology ,Retrospective cohort study ,medicine.disease ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Surgical oncology ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,Clinical significance ,030212 general & internal medicine ,Lymph ,Ovarian cancer ,business ,Lymph node - Abstract
Metastasis in retroperitoneal lymph nodes is found to be relatively chemoresistant according to various studies. The role of systematic lymphadenectomy in advanced epithelial ovarian cancer is a controversial topic. The aim of this study is to determine the rate of lymph node positivity in patients undergoing interval cytoreduction in epithelial ovarian cancer and its effect on recurrence-free and overall survival. Retrospective study of 60 patients with advanced epithelial ovarian cancer who underwent interval cytoreduction between January 2011 and December 2015 was done. The histopathology report was studied, and the percentage of nodal metastases was determined. The overall survival and recurrence-free survival were calculated. The association of node positivity to survival and recurrence pattern was analyzed. Our study found that the rate of lymph node positivity was 25%, and this was comparable to other studies. The median recurrence-free survival (RFS) for all patients was 24.4 months. RFS for node-positive patients was 15.7 and 26.8 months for node-negative patients (p-value 0.002). The Median overall survival for all patients was 73.6 months. The mean overall survival (OS) for patients with positive nodes was 49.9 and 51 months and for patients with negative nodes (p-value 0.492). Lymph nodes are relatively chemoresistant. The presence of nodal metastases has a significant impact on recurrence-free survival. However, its role in overall survival is not established. Systematic lymphadenectomy has prognostic implication in advanced epithelial ovarian cancer.
- Published
- 2017
- Full Text
- View/download PDF